Home › Companies › TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. (TLSI) proxy voting records

How asset managers voted at TriSalus Life Sciences, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• TickerTLSI
• CUSIP issuer number89680M
• SEC CIK1826667

Recent shareholder votes

• May 14, 2026 annual meeting (2025-2026 proxy season): 4 items in TriSalus Life Sciences, Inc.'s official results (Form 8-K, filed May 14, 2026); lowest support 92% of votes cast (Elect Director: Mary Szela). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Explore TriSalus Life Sciences, Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on November 6, 2026. This page is rebuilt weekly; built November 9, 2026.